etomoxir has been researched along with Ventricular Dysfunction, Left in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayakawa, T; Hayashi, K; Kamiya, H; Matsui, H; Murase, K; Numaguchi, Y; Okumura, K; Saburi, Y; Toki, Y | 1 |
| Maisch, B; Rupp, H | 1 |
1 review(s) available for etomoxir and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
[Functional genomics of pressure-loaded cardiomyocytes: etomoxir in heart failure?].
Topics: Animals; Calcium-Transporting ATPases; Enzyme Inhibitors; Epoxy Compounds; Gene Expression Regulation; Heart Failure; Hemodynamics; Humans; Myocardium; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Ventricular Dysfunction, Left | 2002 |
1 other study(ies) available for etomoxir and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Involvement of 1,2-diacylglycerol in improvement of heart function by etomoxir in diabetic rats.
Topics: Animals; Blood Pressure; Carnitine; Ceramides; Diabetes Mellitus, Experimental; Diglycerides; Echocardiography; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Heart Rate; Hypoglycemic Agents; Male; Myocardium; Rats; Rats, Wistar; Streptozocin; Ventricular Dysfunction, Left | 2001 |